a decreasing trendp < 0.001
In particular, we observed a decreasing trend of fluoroquinolones use from 2016 to 2018 ( p < 0.001; Figure 4 ).
In particular, we observed a decreasing trend of fluoroquinolones use from 2016 to 2018 ( p < 0.001; Figure 4 ).
From 2016 to 2018, we also noted a decreasing trend for the use of glycopeptide antibacterials and an increasing trend for first-generation cephalosporins and macrolides. 3.